A proliferation-inducing ligand (APRIL) in neutrophils of patients with oral cavity squamous cell carcinoma

European Cytokine Network

Volumn 23, Issue 3, 2012, Pages 93-100

  Jabłónska, Ewa ^a   Wawrusiewicz Kurylonek, Natalia ^a   Garley, Marzena ^a   Ratajczak Wrona, Wioletta ^a   Antonowicz, Bozena ^a   Dziemiánczyk Pakieła, Dorota ^a   Jabłónski, Jakub ^a   Krȩtowski, Adam ^a   Grabowska, Stanisława Zyta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

A proliferation inducing ligand (APRIL); Oral cavity squamous cell carcinoma (OCSCC); Polymorphonuclear neutrophils (PMNs); The extracellular signal regulated kinases 1 2 (ERK1 2); Toll like receptor 4 (TLR4); Transforming growth factor (TGF )

Indexed keywords

APRIL PROTEIN; CEPHALOSPORIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE SULFATE; PARACETAMOL; TARFAZOLIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURGERY; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NEUTROPHIL; POSTOPERATIVE PAIN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEUTROPHILS; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84868110127     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0311     Document Type: Article

References (33)

1. Mantovani A, Allavena P, Sica A, Balwill F. Cancer-related inflammation. Nature 2008; 454(7203): 436-444.
2. Buonocore S, Haddou NO, Moore F, et al. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+T cell response induced by dendritic cells overexpressiong CD95L. J Leukoc Biol 2008; 84(3): 713-720.
3. WU QD, Wang JH, Condron C, Bouchier-Hayes D, Redmond HP. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physio 2001; 280(4): C814-C822.
4. McKeown ST, Lundy FT, Nelson J, et al. The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol 2006; 42(7): 685-690.
5. Das S, Kar Mahapatra S, Gautam N, Das A, Roy S. Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of L-glutamine. Support Care Cancer 2007; 15(12): 1399-1405.
6. Jablonska E, Puzewska W, Grabowska Z, Jablonski J, Talarek L. VEGF, IL-18 and NO production by neutrophils and their seru levels in patients with oral cavity cancer. Cytokine 2005; 30(3): 93-99.
7. Cassatella MA. On the production of TNF-related apoptosisinducing ligand (TRAIL/Apo-2L) by human neutrophils. J Leukocyte Biol 2006; 79(6): 1140-1149.
8. Scapini P, Bazzoni F, Cassatella MA. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol Lett 2008; 116(1): 1-6.
9. Zen H, Nakashiro K, Shintani S, Sumida T, Aramoto T, Hamakawa H. Detection of circulating cancer cells in human oral squamous cell carcinoma. Int J Oncol 2003; 23(3): 605-610.
10. Jablonska E, Jablonski J, Marcinczyk M, Grabowska Z, Piotrowski L. The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients. Folia Histochem Cytobiol 2008; 46(2): 177-183.
11. Jablonska E, Slodczyk B, Wawrusiewicz-Kurylonek N, et al. Overexpression of B cell-activating factor (BAFF) in neutrophils of oral cavity cancer patients - preliminary study. Neoplasma 2011; 58(3): 211-216.
12. Jablonska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blond mononuclear cells from cancer patients. Eur Cytokine Netw 1998; 9(12): 155-159.
13. Mhawech-Fauceglia P, Kaya G, Sauter G, et al. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 2006; 80(4): 697-704.
14. Mackay F, Tangye SG. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 2004; 4(4): 347-354.
15. Hahne M, Kataoka T, Schröter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998; 188(6): 1185-1190.
16. Hendriks J, Planelles L, de Jong-Odding J, et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005; 12(6): 637-648.
17. Simons MP, Moore JM, Kemp TJ, Griffith TS. Identification of the Mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils Infect Immun 2007; 75(3): 1265-1271.
18. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124(4): 783-801.
19. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17(1): 1-14.
20. Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine 2010; 49(1): 1-9.
21. Jablonska E, Wawrusiewicz-Kurylonek N, Garley M, Kretowski A. TLR4 ligation induces expression of APRIL molecule in human neutrophils-preliminary study. Folia Hist Cytobiol 2012; 50(3). (in press).
22. Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009; 16(3): 183-194.
23. Trellakis S, Bruderek K, Dumitru CA, et al. Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011; 129(9): 2183-2193.
24. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 2009; 27(28): 4709-4717.
25. Schwaller J, Schneider P, Mhawech-Fauceglia P, et al. Neutrophilderived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 2007; 109(1): 331-338.
26. DingW,Wang J, Sun B, et al. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clin Biochem 2009; 42(16-17): 1694-1698.
27. Popovíc B, Jekíc B, Novakovíc I, et al. Bcl-2 expression in oral squamous cell carcinoma. Ann N Y Acad Sci 2007; 1095: 19-25.
28. Moreaux J, Legouffe E, Jourdan E, et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin deprivation and dexamethasone. Blood 2004; 103(8): 3148-3157.
29. Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology 2010; 57(2): 304-316.
30. Jang YS, Kim JH, Seo GY, Kim PH. TGF-α 1 stimulates mouse macrophages to expressAPRILthrough Smad andp38MAPK/CREB pathways. Mol Cells 2011; 32(3): 251-255.
31. Szymkowiak CH, Csernok E, Reinhold D, Bank U, Gross WL, Kekow J. Neutrophils synthesize and activate TGFbeta2. Cytokine 2000; 12(4): 397-400.
32. Schuler PJ, Börger V, Bölke E, et al. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory T cells in human head and neck carcinoma during radio-chemotherapy. Eur J Med Res 2011; 16(2): 57-62.
33. Sawicka-Powierza J, Jablonska E, Kloczko J, Piszcz J, Garley M, Ratajczak-Wrona W. Evaluation of TNF superfamily molecules release by neutrophils and B leukemic cells of patients with chronic B-cell lymphocytic leukemia. Neoplasma 2011; 58(1): 45-50.